{"name":"AnHorn Medicines Co. Ltd.","slug":"anhorn-medicines-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOUE04bXdzMHhBWnNqNE1CWl9PV1NhaU1leGpkb21ZS1Qyc184ZmVUSWhoa1JKem1BeGFWUUNXQ2w1SDd6TFdtS0pXMXQxTktLbUhCSFRyYy1RV1lqZlpoV1c2RUNnMjVRTUhqNjFvUUpOTjRibUw2eGdTbjViZV92dEZiUkx1dmowd3BoNHlWc01NZ0VWX1JkRW54M1lSZkxQZnRQcjZfZldiRUpwa0J6VnROOXExY1g4aGlVQzRXRDVhTzQtaEFJWkl3OGdVbDBwVUczbUtCRFdkY2tTb2EtV1R0aTVVVWxl?oc=5","date":"2025-10-29","type":"trial","source":"prnewswire.com","summary":"AI-Designed Drug AH-001 Complete U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability - prnewswire.com","headline":"AI-Designed Drug AH-001 Complete U.S. Phase I Trial, Demonstrating Excellent Safety and Tolerability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPR0pyQ1Jjbi13UnhHMnFnQU5uY0d6Y0poNUpfVVJ4OWRuZ0JEOUtvb2lTTE1wclIwWlZkQ0JsQUtIYnQ3N0JBb2dWTTJJVHVVaE5OU29zc3NFV2d4SEpYRXNjN0NUdDJwNElnZmZiSXEybnBWREo2Q2JlMWpOVHViR0ZCTzVYWlNLQnVKcU1zazNodmZpNjRmVDIwS1kxc25YYTdPSEMzLWYtdC0zNjkycjlHcHcxMWdabXA1dENkN0dBZUVyNEJhUmJJY3g3Zy1wTGpsR3VBemZIbFNoRUxXOENrMDVxTDZnd1NLNg?oc=5","date":"2025-03-26","type":"trial","source":"prnewswire.com","summary":"AnHorn Medicines Announces First Subject Dosed in AH-001 Phase I Clinical Trial in the United States - prnewswire.com","headline":"AnHorn Medicines Announces First Subject Dosed in AH-001 Phase I Clinical Trial in the United States","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBPdHhZU0NYUTBSN1huR2RFbE0tcVRaWWs0NHpyZm1DaGtYQTlZd3dHLW1NcVliVVlpWlF3UEtIM1lIUGF6REdWQzJNRzhFZW5QbWVQNnE4azY4WS1KbDJUbExFN3pmN3pPZEJzTTlnWmE?oc=5","date":"2025-03-05","type":"pipeline","source":"labiotech.eu","summary":"The 7 hottest biotech companies in Taiwan - labiotech.eu","headline":"The 7 hottest biotech companies in Taiwan","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}